The decrease in LAMC2 and LOXL2 secretion correlated with other phenotypic changes, including decreased clonogenicity, tumor sphere formation, spheroid growth, growth in vivo and increased drug sensitivity. This evidence concerns the gene LOXL2 and neoplasm.